Home Studies HNCIG coordinates major international clinical trials and large-scale collaborative studies that address critical questions in head and neck cancer. These studies involve multiple cooperative groups and thousands of patients worldwide. Click here to Propose a Study. View Ongoing Studies View Completed Studies Sort by: HNCIG Study No. Title Search: Clear 26-005 - Feasibility of Accessing Individual Patient Data (IPD) within HNCIG Member Organisations Chief Investigator(s): Petr Szturz Contact Email: petr.szturz@chuv.ch Acronym: HNCIG-IPD Lead Committee: AIDa Committee Status: In progress 26-010 - Head and Neck Cancer International Group (HNCIG) consensus for clinical practice recommendations on elective nodal irradiation in non-nasopharyngeal squamous cell carcinoma of the head and neck Chief Investigator(s): Pierluigi Bonomo Contact Email: bonomop@aou-careggi.toscana.it Acronym: ENIGMA-HN Lead Committee: Guidelines and Protocol Committee (G&PC) Status: In progress 24-003 - Head and Neck Cancer International Group (HNCIG) consensus for clinical practice recommendations on oligometastatic head and neck cancer Chief Investigator(s): Pierluigi Bonomo, Petr Szturz Contact Email: bonomop@aoucareggi.toscana.it Lead Committee: Young Investigators Committee (YIC) Study Type: Other Population: Curative mixed Tumour Type: HNSSC Status: Completed 22-004 - Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the Delivery of Postoperative Radiation Therapy in Complex Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) Chief Investigator(s): Sandro V Porceddu Contact Email: Sandro.Porceddu@petermac.org Tumour Type: cSCC Status: Reported Read further information 25-004 - Head and Neck Cancer Survivorship Care Assessment and Protocols Chief Investigator(s): Zsuzsanna Iyizoba Ebozue Contact Email: zsuzsanna.iyizoba@nhs.net Acronym: INSPIRE Lead Committee: Young Investigators Committee (YIC) Study Type: Real World Data Population: Curative Tumour Type: HNSSC Status: In progress 24-012 - HNCIG Priority Research Areas project (PRIORITI) Chief Investigator(s): Hisham Mehanna Contact Email: h.mehanna@bham.ac.uk Acronym: PRIORITI Lead Committee: Scientific Clinical Trials Committee (SCTC) Study Type: Survey Population: Curative / R/M Tumour Type: Mixed Status: Completed First12345...Last